-
公开(公告)号：KR101163940B1
公开(公告)日：2012-07-09
申请号：KR1020110008484
申请日：2011-01-27
Applicant: 엘지이노텍 주식회사 , 광주과학기술원
Abstract: PURPOSE: An electrode material and a method for forming a conductive polymer electrode are provided to improve electric conductivity by forming an electrode including metal of the type of a conductive polymer and a nano-wire. CONSTITUTION: A conductive polymer solution comprises a first solvent and a conductive polymer. A mixture is formed by mixing a first solution and a second solution(S501). The first solution is formed by mixing the conductive polymer solution and the first solvent. The second solution comprises a metal nano-wire and D.I(Deionize Water) water. The first solution is formed by mixing the conductive polymer solution and a second solvent. The mixture is coated on a substrate(S503). The mixture is heat-treated(S504).
Abstract translation: 目的：提供电极材料和形成导电聚合物电极的方法，以通过形成包括导电聚合物和纳米线类型的金属的电极来改善导电性。 构成：导电聚合物溶液包含第一溶剂和导电聚合物。 通过混合第一溶液和第二溶液形成混合物（S501）。 第一溶液是通过混合导电聚合物溶液和第一溶剂形成的。 第二种溶液包括金属纳米线和D.I（去离子水）水。 第一溶液是通过混合导电聚合物溶液和第二溶剂形成的。 将混合物涂布在基材上（S503）。 将混合物进行热处理（S504）。
-
Patent Agency Ranking
公开(公告)号：KR102132904B1
公开(公告)日：2020-07-13
申请号：KR1020180098778
申请日：2018-08-23
Applicant: 광주과학기술원 , 차의과학대학교 산학협력단 , 서울대학교병원
IPC: A61K31/4412 , A61K31/522 , A61K31/675 , A61P31/20 , A23L33/10
-
13.发明授权
公开(公告)号：KR101749225B1
公开(公告)日：2017-07-19
申请号：KR1020150048281
申请日：2015-04-06
Applicant: 서울대학교산학협력단 , 광주과학기술원
Abstract: 본원은 CTLA-4의세포외영역단백질또는그 유전자를포함하는면역조절장애신드롬치료용약학조성물을개시한다. 본원에따른조성물은특발성난치성질환으로치료방법이없던, 신체전체적으로다중장기에서자가면역증상을보이는면역조절장애신드롬의치료에유용하게사용될수 있다.
Abstract translation: 本发明公开了用于治疗免疫调节综合征的药物组合物，其包含CTLA-4的胞外域蛋白或其基因。 根据本发明的组合物可以是免疫调节紊乱综合症的治疗中有用似乎在多种器官的免疫症状贯穿本前所未有自，身体护理特发性难治性疾病。
-
公开(公告)号：KR1020140075360A
公开(公告)日：2014-06-19
申请号：KR1020120143628
申请日：2012-12-11
Applicant: 광주과학기술원
Abstract: The present invention relates to peptide inhibiting T cell activity. In phosphoinositide-dependent kinase 1 (PDK1) including a first amino acid sequence of the sequence listing, 513th amino acid, Threonine is substituted with phosphomimic or phosphorylation-disabled amino acid, and the peptide consists of 8 to 50 sequential amino acids including the substituted 513th amino acid. Existing PDK1 regulators are mostly synthetic compounds regulating the activity of PDK1 kinase, and the synthetic compounds have a possibility of causing side effects by widely regulating the PDK1 functions. The peptide in the present invention specifically regulates T cell and NF-κB activities induced by PDK1, thereby being unlikely to cause the side effects.
Abstract translation: 本发明涉及肽抑制性T细胞活性。 在包含序列表的第一个氨基酸序列的磷酸肌醇依赖性激酶1（PDK1）中，第513位氨基酸，苏氨酸被磷酸化或磷酸化残基的氨基酸取代，并且该肽由8至50个连续氨基酸组成，包括经取代 第513位氨基酸。 现有的PDK1调节剂主要是调节PDK1激酶活性的合成化合物，合成化合物可能通过广泛调节PDK1功能而引起副作用。 本发明的肽特异性调节由PDK1诱导的T细胞和NF-κB活性，不可能引起副作用。
-
15.发明公开
公开(公告)号：KR1020160119520A
公开(公告)日：2016-10-14
申请号：KR1020150048281
申请日：2015-04-06
Applicant: 서울대학교산학협력단 , 광주과학기술원
Abstract: 본원은 CTLA-4의세포외영역단백질또는그 유전자를포함하는면역조절장애신드롬치료용약학조성물을개시한다. 본원에따른조성물은특발성난치성질환으로치료방법이없던, 신체전체적으로다중장기에서자가면역증상을보이는면역조절장애신드롬의치료에유용하게사용될수 있다.
-
公开(公告)号：KR1020120086208A
公开(公告)日：2012-08-02
申请号：KR1020110007520
申请日：2011-01-25
Applicant: 엘지이노텍 주식회사 , 광주과학기술원
IPC: H01B13/00 , H01B5/14 , G02F1/1343 , G06F3/041
CPC classification number: H01B13/0003 , G02F1/133 , G02F1/13338 , G02F1/134309 , G06F3/0412 , G06F2203/04103 , H01B5/14
Abstract: PURPOSE: A method for forming a conductive polymer electrode and an electrode material are provided to reduce defects and manufacturing costs in a simple process by forming electrodes without a high temperature process and a vacuum process. CONSTITUTION: A conductive polymer solution is prepared. A mixture solution is formed by mixing an addictive solvent with the conductive polymer solution(S401). The mixture solution is coated on a substrate(S402). The mixture solution is thermally treated(S403).
Abstract translation: 目的：提供一种用于形成导电聚合物电极和电极材料的方法，以通过在没有高温工艺和真空工艺的情况下形成电极来简化工艺中的缺陷和制造成本。 构成：制备导电聚合物溶液。 通过将成瘾溶剂与导电聚合物溶液混合形成混合溶液（S401）。 将混合溶液涂布在基材上（S402）。 对混合溶液进行热处理（S403）。
-
-
-
-
-
Search Results
16
records
(took 0.021 seconds)
